Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Resminostat

EU orphan designation number: EU/3/11/913   
Active ingredient: Resminostat
Indication: Treatment of hepatocellular carcinoma
Sponsor: 4SC AG
Am Klopferspitz 19a, D-82152 Martinsried, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/045/11 (2011)7046 of 27/09/2011